Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark

Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study

(2021) Mohamed Attauabi et al.   JOURNAL OF AUTOIMMUNITY

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

(2020) Bolin Wang et al.   Aging-US

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases

(2020) Carlos Taxonera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration

(2020) Giovanni Damiani et al.   Dermatologic Therapy

Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy

(2020) Lorenzo Norsa et al.   GASTROENTEROLOGY

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

(2020) David T. Rubin et al.   GASTROENTEROLOGY

Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy

(2020) Luca Quartuccio et al.   JOINT BONE SPINE

Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?

(2020) Giovanni Monteleone et al.   Journal of Crohns & Colitis

COVID‐19 diagnosis and management: a comprehensive review

(2020) Giuseppe Pascarella et al.   JOURNAL OF INTERNAL MEDICINE

Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases

(2020) Milena Gianfrancesco et al.   CURRENT OPINION IN RHEUMATOLOGY

COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain

(2020) Rubén Queiro Silva et al.   Dermatologic Therapy

Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.

(2020) Shailendra Singh et al.   GASTROENTEROLOGY

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of chronic liver disease on outcomes of hospitalized patients with COVID‐19: A multicentre United States experience

(2020) Nikroo Hashemi et al.   LIVER INTERNATIONAL

Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes

(2020) Fernando Montero et al.   RHEUMATOLOGY INTERNATIONAL

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review

(2020) Lucile Grange et al.   THERAPIE

Long term respiratory complications of covid-19

(2020) Emily Fraser   BMJ-British Medical Journal

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

(2020) Shintaro Akiyama et al.   ANNALS OF THE RHEUMATIC DISEASES

Hospitalization for COVID‐19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population – a Danish cohort study

(2020) Bente Mertz Nørgård et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of IBD medications on COVID-19 outcomes: results from an international registry

(2020) Ryan C Ungaro et al.   GUT

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

(2020) Jesús Loarce-Martos et al.   RHEUMATOLOGY INTERNATIONAL

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

(2020) George N. Ioannou et al.   JAMA Network Open

Correction to: Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a etrospective cohort study

(2020) Karlijn van Halem et al.   BMC INFECTIOUS DISEASES

Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

(2020) René Cordtz et al.   RHEUMATOLOGY

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

When the entire population is the sample: strengths and limitations in register-based epidemiology

(2014) Lau Caspar Thygesen et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish Civil Registration System

(2011) Carsten Bøcker Pedersen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH